Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D

Affecting about 1 in 12 Americans annually, depression is a leading cause of the global disease burden. While a range of effective antidepressants are now available, failure and relapse rates remain substantial, with intolerable side effect burden the most commonly cited reason for discontinuation....

Full description

Bibliographic Details
Main Authors: Adkins, D E, Clark, S L, Åberg, K, Hettema, J M, Bukszár, J, McClay, J L, Souza, R P, van den Oord, E J C G
Format: Online
Language:English
Published: Nature Publishing Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410623/

Similar Items

Similar Items